<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Indian J Ophthalmol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Indian J Ophthalmol</journal-id>
      <journal-id journal-id-type="publisher-id">IJO</journal-id>
      <journal-title-group>
        <journal-title>Indian Journal of Ophthalmology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0301-4738</issn>
      <issn pub-type="epub">1998-3689</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26576528</article-id>
      <article-id pub-id-type="pmc">4687197</article-id>
      <article-id pub-id-type="publisher-id">IJO-63-678</article-id>
      <article-id pub-id-type="doi">10.4103/0301-4738.169796</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Brief Communications</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Central retinal artery occlusion following orbital tumor resection: Is rapid intervention effective?</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Rajabi</surname>
            <given-names>Mohammad Taher</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Naderan</surname>
            <given-names>Mohammad</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mohammadi</surname>
            <given-names>Seyed Ziaeddin Tabatabaei</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rajabi</surname>
            <given-names>Mohammad Bagher</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran</aff>
      <author-notes>
        <corresp id="cor1"><bold>Correspondence to:</bold> Dr. Mohammad Naderan, Eye Research Center, Farabi Eye Hospital, Qazvin Square, Tehran, Iran. E-mail: <email xlink:href="Moh@Naderan.com">Moh@Naderan.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>8</month>
        <year>2015</year>
      </pub-date>
      <volume>63</volume>
      <issue>8</issue>
      <fpage>678</fpage>
      <lpage>680</lpage>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>11</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>11</day>
          <month>6</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright: &#xA9; 2015 Indian Journal of Ophthalmology</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>A 52-year-old male patient presented at our hospital with unilateral proptosis and vision loss in his left eye. Imaging evaluations showed orbital tumor, so the patient underwent surgery. About an hour later after tumor removal, patient developed sudden vision loss and became no light perception. Fundus evaluation revealed central retinal artery occlusion (CRAO). The patient was treated immediately with ocular massage and anterior chamber paracentesis as well as systemic therapy with mannitol and intravenous administration of acetazolamide. After thirty minutes, he recovered perception to light and then hand motion and 2 h later, it was improved to 1 m counting finger. CRAO following orbital tumor has not been reported before. We recommend ocular examination in all patients that undergo orbital surgery immediately to 2&#x2013;3 h after surgery.</p>
      </abstract>
      <kwd-group>
        <kwd>Central retinal artery occlusion</kwd>
        <kwd>orbital tumor</kwd>
        <kwd>rapid intervention</kwd>
        <kwd>tumor resection</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Central retinal artery occlusion (CRAO) is a very rare condition that happens in 1/10,000 outpatient visit.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref>] This event is sudden and devastating that leads to visual acuity (VA) of counting fingers or less,[<xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref3" ref-type="bibr">3</xref>] thus it is one of the most important topics in ophthalmology needs to immediate intervention. For the first time, we report a patient with postoperation CRAO after orbital tumor resection.</p>
    <sec id="sec1-1">
      <title>Case Report</title>
      <p>A 52-year-old male patient presented at our hospital with progressive unilateral proptosis since 2 years ago and vision loss in his left eye. His left eye VA was 2/10, and right eye was 10/10. Ocular examination revealed 2+ relative afferent pupillary defect in the left eye.</p>
      <p>Computed tomography scan of the patient showed an intraconal mass sticking to superior ophthalmic fissure [<xref ref-type="fig" rid="F1">Fig. 1</xref>]. He underwent tumor resection through inferior transconjunctival approach. The procedure was done without complication, and the early postoperative vision was fine but about an hour later, patient developed sudden vision loss and became no light perception (NLP). For ruling out postoperation hemorrhage, surgical site was evaluated but there was not any hemorrhage there. Fundus examination with indirect ophthalmoscopy revealed typical view of CRAO with the presence of cherry-red spot on the macula, white ground-glass appearance of the retina, and optic disc edema [<xref ref-type="fig" rid="F2">Fig. 2</xref>]. For decreasing intraocular pressure and establishing retinal reperfusion, immediate ocular massage and anterior chamber paracentesis as well as systemic therapy with mannitol were done. After 30 min, the patient recovered perception to light and then hand motion. Two hours later, it was improved to 1 m counting finger, but he complained a large central scotoma. His VA improved to 20/200 the day after the surgery, and he complained of diplopia. Perimetry showed inferotemporal scotoma that involved central part. After 3 weeks, his VA improved to 4/10 and scotoma extension was decreased.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Orbital computed tomography-scan of the patient shows well-defined dumble shaped intraconal orbital mass that pushed the optic nerve superomedially and extending to the supra orbital fissure</p>
        </caption>
        <graphic xlink:href="IJO-63-678-g001"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Fundus photograph 3 days after the surgery showing cherry-red spot on the macula and white ground-glass appearance of the retina and also optic disc edema</p>
        </caption>
        <graphic xlink:href="IJO-63-678-g002"/>
      </fig>
      <p>Medical workup did not show any evidence of collagen vascular or cardiovascular, hematologic, and neurologic disorders. Systemic investigations including fasting blood sugar, lipid profile, and homocysteine levels all were normal. Pathologic evaluation of the tumor was schwannoma with mucinous transformation.</p>
    </sec>
    <sec sec-type="discussion" id="sec1-2">
      <title>Discussion</title>
      <p>CRAO is usually caused by a thrombus or embolus that resulting to reduce blood perfusion of the retina.[<xref rid="ref4" ref-type="bibr">4</xref>] It clinically presents as sudden painless acute unilateral or bilateral vision loss in the range of counting fingers to NLP. The rate of spontaneously recanalization of the artery is about 15%[<xref rid="ref5" ref-type="bibr">5</xref>] with timely intervention, the prognosis is very poor as only 61% of patients can regain a final VA of 6/120 or less.[<xref rid="ref3" ref-type="bibr">3</xref>] One of the typical findings in CRAO is cherry-red spot that is found in about 90% of cases.</p>
      <p>There is a golden time of 90&#x2013;120 min after occlusion to perform interventions to improve vision, however there is no approved modality to be effective in the treatment of CRAO,[<xref rid="ref6" ref-type="bibr">6</xref>] but some methods such as immediate ocular massage and anterior chamber paracentesis, use of drugs such as intravenous acetazolamide and mannitol or inhalation of a mixture of 95% oxygen and 5% carbon dioxide (carbogen), all aimed to reduce intraocular pressure and improving blood flow to the eye. Without doing these modalities, &lt;10% of patients can recover meaningful vision.[<xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref7" ref-type="bibr">7</xref>]</p>
      <p>Multiple theories for CRAO during surgical procedures have been proposed; a prolonged hypotensive status and reduction in blood flow or also increasing intraocular pressure including ocular compression during certain ocular surgical procedures associated with ocular ischemia,[<xref rid="ref5" ref-type="bibr">5</xref>] causing ischemia of the retina and may lead to CRAO and vision loss after surgery.[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref8" ref-type="bibr">8</xref>] Although we did not face any significant drop in blood pressure (BP) during intervention but regarding differences in populations may be our patient was very sensitive to even small drop in BP that could lead to CRAO.</p>
      <p>In another theory, K&#xF6;rner-Stiefbold[<xref rid="ref9" ref-type="bibr">9</xref>] explains that retrobulbar masses such as hematoma, neoplasms, and retrobulbar injections may compress central retinal artery and lead to arterial occlusion and decrease blood perfusion causing CRAO.</p>
      <p>A more likely explanation in that ocular vascular damage may be happened by surgical maneuvers, and it will results in activation and aggregation of platelets and activated platelets release serotonin (5-hydroxytryptamine). Serotonin is a vasoconstrictor and inducing transient arterial spasm, causing transient or complete arterial occlusion leading to ischemia of retina and creating CRAO.[<xref rid="ref10" ref-type="bibr">10</xref>]</p>
      <p>We recommend that in all patients with orbital tumors that undergo tumor removal, the ocular exam should be performed immediately, and every 1&#x2013;3 h after the surgery to rule out CRAO, as delay in diagnosis and intervention could eventuate to severe vision loss.</p>
      <sec id="sec2-1">
        <title>Financial support and sponsorship</title>
        <p>Nil.</p>
      </sec>
      <sec id="sec2-2">
        <title>Conflicts of interest</title>
        <p>There are no conflicts of interest.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hayreh</surname>
              <given-names>SS</given-names>
            </name>
          </person-group>
          <article-title>Acute retinal arterial occlusive disorders</article-title>
          <source>Prog Retin Eye Res</source>
          <year>2011</year>
          <volume>30</volume>
          <fpage>359</fpage>
          <lpage>94</lpage>
          <pub-id pub-id-type="pmid">21620994</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Magargal</surname>
              <given-names>LE</given-names>
            </name>
          </person-group>
          <article-title>Central retinal artery obstruction and visual acuity</article-title>
          <source>Ophthalmology</source>
          <year>1982</year>
          <volume>89</volume>
          <fpage>14</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">7070767</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hayreh</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Zimmerman</surname>
              <given-names>MB</given-names>
            </name>
          </person-group>
          <article-title>Central retinal artery occlusion: Visual outcome</article-title>
          <source>Am J Ophthalmol</source>
          <year>2005</year>
          <volume>140</volume>
          <fpage>376</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">16138997</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>AW</given-names>
            </name>
          </person-group>
          <article-title>Management of acute central retinal artery occlusion</article-title>
          <source>Nat Clin Pract Neurol</source>
          <year>2008</year>
          <volume>4</volume>
          <fpage>376</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="pmid">18542123</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hayreh</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Podhajsky</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Ocular neovascularization with retinal vascular occlusion. II. Occurrence in central and branch retinal artery occlusion</article-title>
          <source>Arch Ophthalmol</source>
          <year>1982</year>
          <volume>100</volume>
          <fpage>1585</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="pmid">6182865</pub-id>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hayreh</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Kolder</surname>
              <given-names>HE</given-names>
            </name>
            <name>
              <surname>Weingeist</surname>
              <given-names>TA</given-names>
            </name>
          </person-group>
          <article-title>Central retinal artery occlusion and retinal tolerance time</article-title>
          <source>Ophthalmology</source>
          <year>1980</year>
          <volume>87</volume>
          <fpage>75</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">6769079</pub-id>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Atebara</surname>
              <given-names>NH</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Cater</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Efficacy of anterior chamber paracentesis and Carbogen in treating acute nonarteritic central retinal artery occlusion</article-title>
          <source>Ophthalmology</source>
          <year>1995</year>
          <volume>102</volume>
          <fpage>2029</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="pmid">9098313</pub-id>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Myers</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Hamilton</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Bogosian</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Wagner</surname>
              <given-names>TA</given-names>
            </name>
          </person-group>
          <article-title>Visual loss as a complication of spine surgery. A review of 37 cases</article-title>
          <source>Spine (Phila Pa 1976)</source>
          <year>1997</year>
          <volume>22</volume>
          <fpage>1325</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">9201835</pub-id>
        </element-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>K&#xF6;rner-Stiefbold</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Central retinal artery occlusion &#x2013; Etiology, clinical picture, therapeutic possibilities</article-title>
          <source>Ther Umsch</source>
          <year>2001</year>
          <volume>58</volume>
          <fpage>36</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">11217485</pub-id>
        </element-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hayreh</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Piegors</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Heistad</surname>
              <given-names>DD</given-names>
            </name>
          </person-group>
          <article-title>Serotonin-induced constriction of ocular arteries in atherosclerotic monkeys. Implications for ischemic disorders of the retina and optic nerve head</article-title>
          <source>Arch Ophthalmol</source>
          <year>1997</year>
          <volume>115</volume>
          <fpage>220</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">9046257</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
